News
-
-
-
-
-
-
PRESS RELEASE
Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
Moderna submits application to FDA for review of Spikevax 2025-2026 formula targeting SARS-CoV-2 variant LP.8.1, based on FDA guidance for COVID-19 vaccine update. Learn more about Moderna's innovative mRNA technology -
-
-
-